跳至主要内容
临床试验/NCT00318162
NCT00318162Unknown1 期

Randomized Double-Blind Trial of Low-Dose Naltrexone for Children With PDD

Hadassah Medical Organization1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2006年4月26日最近更新:
适应症
相关药物

试验速览

阶段
1 期
入组人数
50
试验地点
1
主要终点
play observation

研究概览

简要总结

This study will examine the effects of low-dose naltrexone (LDN) on children with autistic spectrum disorders. The investigators hope to show a positive effect on social functioning and language.

详细描述

Fifty children aged three to six years will be recruited for the study. They will be randomly assigned to receive either LDN or placebo for two months after which the treatment groups will be switched over. Assessments of functioning will be obtained from a video-taped play session, and by parent and teacher questionnaires at baseline, after two months and after four months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double

入排标准

年龄范围
3 Years 至 6 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of PDD

排除标准

  • 未提供

结局指标

主要结局

play observation

Autism Behavior Checklist (ABC) questionnaire

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Trial of Low-Dose Naltrexone for Children With... | 临床试验